These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11566673)

  • 1. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
    Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
    AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
    Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
    Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
    Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
    Cedrone A; Pompili M; Sallustio G; Lorenzelli GP; Gasbarrini G; Rapaccini GL
    Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
    Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
    AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma.
    Numata K; Isozaki T; Ozawa Y; Sakaguchi T; Kiba T; Kubota T; Ito A; Sugimori K; Shirato K; Morimoto M; Tanaka K
    AJR Am J Roentgenol; 2003 Jan; 180(1):143-9. PubMed ID: 12490493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent.
    Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Kim H; Lee SJ; Lim JH
    J Ultrasound Med; 2002 Apr; 21(4):391-401. PubMed ID: 11934096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial.
    Minami Y; Kudo M; Chung H; Kawasaki T; Yagyu Y; Shimono T; Shiozaki H
    AJR Am J Roentgenol; 2007 Feb; 188(2):489-94. PubMed ID: 17242259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced, wide-band, phase inversion harmonic power Doppler imaging of hepatocellular carcinoma.
    Janica J; Serwatka W; Polaków J; Kordecki K; Łebkowska U; Walecki J; Dobrzycki S
    Med Sci Monit; 2004 Jun; 10 Suppl 3():32-5. PubMed ID: 16538196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation.
    Minami Y; Kitai S; Kudo M
    Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced color flows in hepatic tumors.
    Yang CC; Chen CH; Yeh YH
    Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography.
    Minami Y; Kudo M; Kawasaki T; Chung H; Ogawa C; Shiozaki H
    AJR Am J Roentgenol; 2004 Jul; 183(1):153-6. PubMed ID: 15208130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
    Dill-Macky MJ; Asch M; Burns P; Wilson S
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound.
    Cioni D; Lencioni R; Bartolozzi C
    Eur Radiol; 2000; 10(10):1570-5. PubMed ID: 11044926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience.
    Minami Y; Kudo M; Hatanaka K; Kitai S; Inoue T; Hagiwara S; Chung H; Ueshima K
    Liver Int; 2010 May; 30(5):759-64. PubMed ID: 20456042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy.
    Koito K; Namieno T; Ichimura T; Hirokawa N; Syonai T; Hareyama M; Katsuramaki T; Hirata K; Nishi M
    AJR Am J Roentgenol; 2000 Feb; 174(2):337-41. PubMed ID: 10658701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of contrast-enhanced ultrasonography with dynamic flow imaging to evaluate therapeutic effects for hepatocellular carcinoma.
    Hotta N; Tagaya T; Maeno T; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
    Hepatogastroenterology; 2003; 50(54):1867-71. PubMed ID: 14696421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.